教育經曆：
2010-09 至 2014-06，河南科技大學，動植物檢專業，獲學士學位
2014-09 至 2021-06，華中農業大學，預防獸醫學專業，獲博士學位
工作經曆：
2001/07-2021/12 廣西揚翔股份有限公司（單位） 獸醫師（職務）
2022/01-至今 伟徳国际官网登录入口（單位） 講師（職務）
研究方向：
1. 新型疫苗納米顆粒佐劑研制
2. 動物分子病原學研究與新型獸藥創制
主要在研項目：
1. 台州市科技局，《新型納米黏膜佐劑的研發及其增強PDCoV滅活疫苗免疫效果評價》（23gya02），2023.5-2025.12,12萬，主持。
2. 國家自然科學基金項目，《mRNA疫苗遞送系統的構建及其增強豬腸道粘膜免疫應答作用機制的研究》（32370987），2024.1-2027.12，50萬，參與。
已完成的主要科研項目
1. 國家自然科學基金項目，《豬環曲病毒3C樣蛋白酶的鑒定及其小分子抑制劑的篩選》（31872485），2019.1-2022.12，61萬，參與。
近期代表性論文：
1. Shangen Xu#; Zhi Zhao#; Chenxi Sun; Yile Ji; Qingshuang Luan; Qihong Zhang ; Zheng Jin; Kai Zhao; Immunoprotective effect of chitosan nanoparticles with different particle sizes against H9N2 avian influenza infection. Poultry Science, 2024; 104: 104559.
2. Shangen Xu; Lu Yu; Qiaoyang Teng; Xuesong Li; Zheng Jin; Yang Qu; Jiawei Li; Qihong Zhang; Zejun Li*; Kai Zhao*; Enhance immune response to H9 AIV DNA vaccine based on polygene expression and DGL nanoparticle encapsulation, Poultry Science, 2023, 102(10)(102925).
3. Shangen Xu; Hailing Lan; Qiaoyang Teng; Xuesong Li; Zheng Jin Zheng Jin; Yang Qu; Jiawei Li; Qihong Zhang; Hong Kang; Tan Hui Yin; Zejun Li*; Kai Zhao*; An immune-enhanced multivalent DNA nanovaccine to prevent H7 and H9 avian influenza virus in mice, International Journal of Biological Macromolecules, 2023, 251(126286).
4. Shangen Xu; Junwei Zhou; Yingjin Chen; Xue Tong; Zixin Wang; Jiahui Guo; Jiyao Chen; Liurong Fang; Dang Wang*; Shaobo Xiao*; Characterization of self-processing activities and substrate specificities of porcine torovirus 3C-like protease, Journal of Virology, 2020, 94(20): e01282-20.
近期代表性成果
1. Shangen Xu; Lu Yu; Qiaoyang Teng; Xuesong Li; Zheng Jin; Yang Qu; Jiawei Li; Qihong Zhang; Zejun Li*; Kai Zhao*; Enhance immune response to H9 AIV DNA vaccine based on polygene expression and DGL nanoparticle encapsulation, Poultry Science, 2023, 102(10)(102925)
2. Shangen Xu; Hailing Lan; Qiaoyang Teng; Xuesong Li; Zheng Jin Zheng Jin; Yang Qu; Jiawei Li; Qihong Zhang; Hong Kang; Tan Hui Yin; Zejun Li*; Kai Zhao*; An immune-enhanced multivalent DNA nanovaccine to prevent H7 and H9 avian influenza virus in mice, International Journal of Biological Macromolecules, 2023, 251(126286)
3. Shangen Xu; Junwei Zhou; Yingjin Chen; Xue Tong; Zixin Wang; Jiahui Guo; Jiyao Chen; Liurong Fang; Dang Wang*; Shaobo Xiao*; Characterization of self-processing activities and substrate specificities of porcine torovirus 3C-like protease, Journal of Virology, 2020, 94(20): e01282-20
4. Jiyao Chen; Zhuang Li; Jiahui Guo; Shangen Xu; Junwei Zhou; Qian Chen; Xue Tong; Dang Wang; Guiqing Peng; Liurong Fang; Shaobo Xiao*; SARS-CoV-2 nsp5 exhibits stronger catalytic activity and interferon antagonism than its SARS-CoV ortholog, Journal of Virology, 2022, 96(8):e00037-22
5. Zhi Zhao; Jinyu Han; Shangen Xu; Zheng Jin; Tanhui Yin; Kai Zhao*; Amoxicillin encapsulated in the N-2-hydroxypropyl trimethyl ammonium chloride chitosan and N,O-carboxymethyl chitosan nanoparticles: Preparation, characterization, and antibacterial activity, International Journal of Biological Macromolecules, 2022, 221: 613-622
6. Zhi Zhao; Jinyu Han; Shangen Xu; Zheng Jin; Tanhui Yin; Kai Zhao*; Amoxicillin encapsulated in the N-2-hydroxypropyl trimethyl ammonium chloride chitosan and N,O-carboxymethyl chitosan nanoparticles: Preparation, characterization, and antibacterial activity, International Journal of Biological Macromolecules, 2022, 221: 613-622
